Genocea Biosciences
GNCA
#10054
Rank
NZ$0 M
Marketcap
$0.0001673
Share price
-85.71%
Change (1 day)
N/A
Change (1 year)

P/E ratio for Genocea Biosciences (GNCA)

P/E ratio on February 24, 2023 (TTM): -0.0002

According to Genocea Biosciences 's latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is -0.000192308. At the end of 2021 the company had a P/E ratio of -2.42.

P/E ratio history for Genocea Biosciences from 2014 to 2022

PE ratio at the end of each year

Year P/E ratio Change
2021-2.4215.84%
2020-2.09125.75%
2019-0.9241
2017-0.5859-75.12%
2016-2.35-19.14%
2015-2.91-1.84%
2014-2.97

P/E ratio for similar companies or competitors

Company P/E ratio P/E ratio differencediff. Country
-4.59 2,388,838.58%๐Ÿ‡บ๐Ÿ‡ธ USA
-1.24 644,293.37%๐Ÿ‡บ๐Ÿ‡ธ USA
56.5-29,378,648.99%๐Ÿ‡บ๐Ÿ‡ธ USA
-0.3210 166,839.49%๐Ÿ‡บ๐Ÿ‡ธ USA
14.4-7,470,200.05%๐Ÿ‡บ๐Ÿ‡ธ USA

How to read a P/E ratio?

The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.

Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.